Yixin Zhai

Changhongjie, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Treatment prioritization of chemotherapy-anchored regimens after EGFR-TKI failure in EGFR-mutant NSCLC: a systematic review, pairwise meta-analysis and Bayesian network meta-analysis with probabilistic multi-criteria decision analysis.

Treatment prioritization of chemotherapy-anchored regimens after EGFR-TKI failure in EGFR-mutant NSCLC: a systematic review, pairwise meta-analysis and Bayesian network meta-analysis with probabilistic multi-criteria decision analysis.

Journal: Frontiers in immunology

Published: April 24, 2026

Synergistic Antitumor Activity of HAT Inhibitor A485 and XPO1 Inhibitor KPT8602 in Multiple Myeloma.

Synergistic Antitumor Activity of HAT Inhibitor A485 and XPO1 Inhibitor KPT8602 in Multiple Myeloma.

Journal: Cancer medicine

Published: October 11, 2025

Programmed-Cell-Death-Related Signature Reveals Immune Microenvironment Characteristics and Predicts Therapeutic Response in Diffuse Large B Cell Lymphoma.

Programmed-Cell-Death-Related Signature Reveals Immune Microenvironment Characteristics and Predicts Therapeutic Response in Diffuse Large B Cell Lymphoma.

Journal: Biomedicines

Published: August 13, 2025

Anoikis classification of lung squamous cell carcinoma reveals correlation with clinical prognosis and immune characteristics.

Anoikis classification of lung squamous cell carcinoma reveals correlation with clinical prognosis and immune characteristics.

Journal: Annals of medicine

Published: June 14, 2025

High-dose vitamin C potently induces apoptosis in acute lymphoblastic leukemia by activating ER stress response.

High-dose vitamin C potently induces apoptosis in acute lymphoblastic leukemia by activating ER stress response.

Journal: Human & experimental toxicology

Published: May 30, 2025

Targeting EP300 in diffuse large b-cell lymphoma: efficacy of A485 and synergistic effects with XPO1 inhibition.

Targeting EP300 in diffuse large b-cell lymphoma: efficacy of A485 and synergistic effects with XPO1 inhibition.

Journal: BMC cancer

Published: January 21, 2025

Identification of Potential Biomarkers for Intervention of AMG-176 in the Chronic Lymphocytic Leukemia Based on Untargeted Metabolomic Analysis.

Identification of Potential Biomarkers for Intervention of AMG-176 in the Chronic Lymphocytic Leukemia Based on Untargeted Metabolomic Analysis.

Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Published: December 17, 2024

SUMOylation-related genes define prognostic subtypes in stomach adenocarcinoma: integrating single-cell analysis and machine learning analyses.

SUMOylation-related genes define prognostic subtypes in stomach adenocarcinoma: integrating single-cell analysis and machine learning analyses.

Journal: Frontiers in immunology

Published: November 13, 2024

A Cuproptosis-related lncRNA Signature for Prognostic Stratification and Immunotherapeutic Implications in Lung Adenocarcinoma.

A Cuproptosis-related lncRNA Signature for Prognostic Stratification and Immunotherapeutic Implications in Lung Adenocarcinoma.

Journal: Current molecular medicine

Published: October 25, 2024

Engineered dCas12f1-SAM enables robust transcriptional activation and gain-of-function screening in primary human cells.

Engineered dCas12f1-SAM enables robust transcriptional activation and gain-of-function screening in primary human cells.

Journal: Nature communications

Published: April 09, 2024

The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia.

The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia.

Journal: Cell death discovery

Published: January 10, 2024

Comparison of blinatumomab and CAR T-cell therapy in relapsed/refractory acute lymphoblastic leukemia: a systematic review and meta-analysis.

Comparison of blinatumomab and CAR T-cell therapy in relapsed/refractory acute lymphoblastic leukemia: a systematic review and meta-analysis.

Journal: Expert review of hematology

Published: December 22, 2023

Showing 1-12 of 21

Last Updated: 09/26/2026